| Trial registration number
|
IRCT20210901052358N4 |
Full text link
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/62832
|
First author
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Shahid Beheshti University of Medical Sciences
|
Contact
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mpajouhesh@sbmu.ac.ir
|
Registration date
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2022-04-13
|
Recruitment status
Last imported at : June 20, 2022, 7:32 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Open label
|
Center
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Laboratory confirmation of COVID-19 virus by RT-PCR or imaging findings consistent with COVID-19
Severe disease (respiratory rate more than 30 per minute, oxygen saturation less than 94%, or pulmonary infiltration more than 50% in both lungs)
Age above 18 years
Willingness to participate in this study
|
Exclusion criteria
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Number of arms
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Shahid Beheshti University of Medical Sciences
|
Inclusion age min
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Severe disease at enrollment
|
Severity scale
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
6: Severe disease at enrollment
|
Total sample size
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
60
|
primary outcome
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mortality
Intubation requirement
|
Notes
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Not reported
|
Arms
Last imported at : April 13, 2022, 11:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "jours 1 and 3", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "jours 1, 3 and 5", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}]
|